Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 48,000 shares at $49.21 ($2.4M) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($2.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.21 | 14,860 | $731K | 30.7% |
| 2 | $49.21 | 14,860 | $731K | 30.7% |
| 3 | $50.19 | 9,140 | $459K | 19.3% |
| 4 | $50.19 | 9,140 | $459K | 19.3% |
| Total | $49.58 avg | 48,000 | $2.4M | 100% |
| Filing → |
| IONS | SELL | 2026-03-11 | $24.2M | — | Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |